These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6482431)

  • 21. Transformation of the 8-9 S molybdate-stabilized estrogen receptor from low-affinity to high-affinity state without dissociation into subunits.
    Redeuilh G; Secco C; Mester J; Baulieu EE
    J Biol Chem; 1987 Apr; 262(12):5530-5. PubMed ID: 3571221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor activation precedes transformation. Effects of ionic strength, temperature, and molybdate.
    Müller RE; Traish AM; Wotiz HH
    J Biol Chem; 1983 Aug; 258(15):9227-36. PubMed ID: 6874687
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation and immunorecognition by a monoclonal antibody of the tamoxifen-estrogen receptor complex.
    Giambiagi N; Pasqualini JR
    Biochim Biophys Acta; 1986 Oct; 883(3):559-66. PubMed ID: 3756221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
    Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
    Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of a high affinity anti-estrogen (alpha-[4-pyrrolidinoethoxy]phenyl-4-hydroxy-alpha'-nitrostilbene, CI628M) with uterine estrogen receptors.
    Katzenellenbogen BS; Pavlik EJ; Robertson DW; Katzenellenbogen JA
    J Biol Chem; 1981 Mar; 256(6):2908-15. PubMed ID: 7204382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF; Singh RK; Mak P; Callard GV
    Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of estrogen receptor to uterine nuclei. Salt-extractable versus salt-resistant receptor-estrogen complexes.
    Traish AM; Müller RE; Wotiz HH
    J Biol Chem; 1977 Oct; 252(19):6823-30. PubMed ID: 893443
    [No Abstract]   [Full Text] [Related]  

  • 31. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
    Evans E; Baskevitch PP; Rochefort H
    Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement for a reduced sulphydryl entity in the protection of molybdate-stabilized estrogen receptor.
    Ratajczak T; Samec AM; Hähnel R
    FEBS Lett; 1982 Nov; 149(1):80-4. PubMed ID: 7152037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recognition of the activated form of estrogen receptor bound to estradiol and tamoxifen by a monoclonal antibody].
    Giambiagi N; Pasqualini JR
    Pathol Biol (Paris); 1986 Oct; 34(8):937-42. PubMed ID: 3537937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody to the estrogen receptor discriminates between the nonactivated and activated estrogen- and anti-estrogen-receptor complexes.
    Borgna JL; Fauque J; Rochefort H
    Biochemistry; 1984 May; 23(10):2162-8. PubMed ID: 6733078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique molecular properties of a urea- and salt-stable DNA-binding estrogen receptor dimer covalently labeled with the antiestrogen [3H]desmethylnafoxidine aziridine. A comparison with the estrogen-receptor complex.
    Hutchens TW; McNaught RW; Yip TT; Suzuki T; Li CM; Besch PK
    Mol Endocrinol; 1990 Feb; 4(2):255-67. PubMed ID: 2330004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of the estrogen receptors contained in the MtTF4 tumor whose growth is inhibited by estradiol: 17 beta-estradiol, 17 alpha-estradiol and DNA bindings.
    Albaladejo V; Pharaboz MO; Morel Y; Andre J
    J Steroid Biochem; 1986 Jul; 25(1):29-36. PubMed ID: 3747513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding of [3H]oestradiol-receptor complexes to calf uterine chromatin.
    Ruh TS; Ross P; Wood DM; Keene JL
    Biochem J; 1981 Oct; 200(1):133-42. PubMed ID: 7332536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
    Giambiagi N; Pasqualini JR
    J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sulfhydryl reagents on uterine nuclear estrogen receptors labeled by in vitro exchange with [3H]estradiol or [3H]4-hydroxytamoxifen.
    Attardi B
    J Recept Res; 1984; 4(7):787-800. PubMed ID: 6527361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salt-induced transformation of the human myometrial estrogen receptor.
    Lukola A; Punnonen R; Tähtinen U
    J Steroid Biochem; 1981 Dec; 14(12):1241-7. PubMed ID: 7329060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.